Home Novo Nordisk to end German sales of new insulin drug after price row
 

Keywords :   


Novo Nordisk to end German sales of new insulin drug after price row

2015-07-01 20:23:39| Biotech - Topix.net

COPENHAGEN: Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy about the high cost of modern medicines.

Tags: price end sales german

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 3
23.11
23.11GEN FACTORY CARVE7.7 2525.5
23.11110
23.11 ssp
23.11L
23.11
23.11 DVD-BOX6
More »